84 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
AND GOVERNANCE (ESG) AND RELATED MATTERS
Our ESG strategy is focused on areas that are material to our business and clearly connected to our business … operations. We expect our ESG strategy to evolve as we continue to assess the appropriate framework for our disclosures and appropriate metrics to measure
8-K
EX-99.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
of industry experience and is an internationally recognized expert in neuropsychiatry, drug research and development, and regulatory strategy. We look
8-K
EX-99.1
myuepbgfyjds gemu93f
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
52rpekyj
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
ohxd3skwl0ldicqg
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
DEFA14A
j954epc3euhua
16 May 22
Additional proxy soliciting materials
6:32pm
DFAN14A
23rtko4ciwhvqrpu
16 May 22
Additional proxy materials by non-management
2:04pm
DFAN14A
EX-99.1
2zogyuee5zs jaxr0nk
16 May 22
Additional proxy materials by non-management
2:04pm
8-K
EX-99.1
ewcz u0vip8yaah7kz13
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DFAN14A
l7wzmgpfcypupi
12 May 22
Additional proxy materials by non-management
2:06pm